ReviewFrontiers in plant science2026
Molecular mechanisms and application potential of MYC2 transcription factor-mediated plant stress responses.
Review in Frontiers in plant science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plant adaptation to drought, salinity, temperature extremes, pathogens, and herbivorous insects depends on coordinated hormone signalling, transcriptional control, and metabolic reprogramming. The jasmonic acid (JA) pathway is a major regulator of defence and the growth-defence trade-off, and the bHLH transcription factor MYC2 is a central node in JA output. Mechanistically, MYC2 is controlled through demonstrated protein-protein interactions with JAZ repressors, MED25, and selected transcriptional or chromatin regulators; it binds G-box-related cis-elements to regulate specific promoters, whereas many reported links to LOX/AOS, CBF, and antioxidant pathways are transcriptional or pathway-level rather than physical interactions. This integrative narrative review compares MYC2 orthologues across species, distinguishes MYC2-specific functions from those shared with MYC3/MYC4 or other clade IIIe bHLHs, and organises beneficial and detrimental stress phenotypes around pathogen lifestyle, target-gene polarity, tissue and developmental context, paralogue redundancy, and experimental design. We integrate genome-wide DNA-binding, transcriptomic, metabolomic, and protein-level studies, and critically evaluate demonstrated versus prospective applications of CRISPR/Cas genome editing. The synthesis identifies regulatory strategies that may exploit MYC2 networks whilst limiting growth, defence, and quality trade-offs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.